Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows.
Worries over health-related costs are plaguing the minds of older Americans of all backgrounds, a new poll suggests.